- NCIt
- C5111
Loading cancer entity…
Loading cancer entity…
Variants & evidence
3 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CTNNB1 Exon 3 Mutation3 | ||||||||
| (diagnostic) | Adamantinomatous CraniopharyngiomaALIAS | Diagnostic | B | Supports Positive | 4 | submitted | EID12111Assessment of beta-catenin mutations in a large collections of pituitary adenomas (n=60) and craniopharynangiomas (n=41), identified CTNNB1 exon 3 mutations in 77% of craniopharynangiomas, all of the … (full text at CIViC) PMID 15891929 · Buslei et al., 2005 · Open in CIViC | civic |
| 〃 | Adamantinomatous CraniopharyngiomaALIAS | Diagnostic | B | Supports Positive | 4 | submitted | EID12112Whole-exome sequencing identified CTNNB1 mutations in 11 of 12 (92%) of adamantinomatous craniopharyngiomas examined. No other recurrent mutations or genomic aberrations were identified. Targeted se… (full text at CIViC) PMID 24413733 · Brastianos et al., 2014 · Open in CIViC | civic |
| 〃 | Adamantinomatous CraniopharyngiomaALIAS | Diagnostic | B | Supports Positive | 4 | submitted | EID12113CTNNB1 sequencing a cohort of 80 adamantinomatous craniopharyngiomas and 35 papillary craniopharyngiomas identified CTNNB1 activating mutations exclusively in the adamantinomatous subtype (in 79 or 8… (full text at CIViC) PMID 26927026 · Hölsken et al., 2016 · Open in CIViC | civic |
Data updated 16 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.